Antiphospholipid syndrome - management
APS mgmt · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
An acquired autoimmune thrombophilia defined by persistent antiphospholipid antibodies with thrombosis or pregnancy morbidity. Management centres on secondary prevention with anticoagulation, with warfarin preferred over DOACs especially in triple-positive patients.
Red flags
- Multi-organ thrombosis (catastrophic APS)
- Recurrent thrombosis on adequate anticoagulation
- Severe thrombocytopenia with bleeding and clotting
- Pregnancy complications (pre-eclampsia, fetal loss)
- New neurological or renal deterioration
Assessment
Differential diagnosis
- Inherited thrombophilia
- Systemic lupus erythematosus
- Catastrophic antiphospholipid syndrome
- Thrombotic microangiopathy
- Heparin-induced thrombocytopenia
Investigations
- Lupus anticoagulant, anticardiolipin, anti-beta2-glycoprotein-I (confirmed at 12 weeks)
- FBC (thrombocytopenia common)
- Renal and liver function
- Imaging of thrombotic site
- Autoimmune screen (ANA, dsDNA) for associated SLE
- Pregnancy monitoring where relevant
Management
- Confirm persistent antiphospholipid antibodies alongside a qualifying clinical event
- Risk-stratify by antibody profile (triple positivity = highest risk) and event type (venous vs arterial)
- For venous thrombosis start warfarin targeting INR 2.0-3.0 after initial heparin overlap
- Avoid DOACs in APS, particularly triple-positive and arterial disease (higher recurrence)
- For arterial or recurrent thrombosis use higher-intensity warfarin or add antiplatelet therapy per specialist advice
- Treat thrombotic APS indefinitely given high recurrence risk
- In obstetric APS use low-dose aspirin plus prophylactic/therapeutic LMWH through pregnancy
- Consider hydroxychloroquine and statins as adjuncts, and address cardiovascular risk factors
- Avoid oestrogen-containing contraception; counsel on pregnancy planning
- Monitor for progression to catastrophic APS and manage flares promptly
Drugs & doses
Warfarin PO titrated to INR 2.0-3.0 (venous APS)
Low-molecular-weight heparin therapeutic dose as bridge / in pregnancy
Aspirin 75-100 mg PO once daily (obstetric APS and some arterial cases)
Hydroxychloroquine 200-400 mg PO daily (adjunct, especially with SLE)
Disposition
Haematology/rheumatology shared care; anticoagulation clinic; obstetric medicine for pregnancy; escalate catastrophic presentations to critical care.
Complications & pitfalls
- Recurrent venous and arterial thrombosis
- Pregnancy loss and placental insufficiency
- Catastrophic antiphospholipid syndrome
- Thrombocytopenia
- Valvular heart disease and livedo
Exam pearls
- Warfarin, not DOACs, is standard for thrombotic APS
- Triple positivity carries the highest recurrence and the strongest contraindication to DOACs
- Obstetric APS needs aspirin plus LMWH, not warfarin (teratogenic)
- A sudden multi-organ presentation signals catastrophic APS - a medical emergency
- Avoid oestrogen contraception in antiphospholipid-positive patients
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.